Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
about
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutationConvergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancerMutation of the INI1 gene in composite rhabdoid tumor of the endometriumGene of the month: SMARCB1Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted TherapyATP-dependent chromatin remodeling complexes as novel targets for cancer therapySWI/SNF chromatin remodeling complexes and cancerReverse genetic analysis of the yeast RSC chromatin remodeler reveals a role for RSC3 and SNF5 homolog 1 in ploidy maintenanceSMARCB1-mediated SWI/SNF complex function is essential for enhancer regulationGeneration of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.Nonnegative matrix factorization: an analytical and interpretive tool in computational biology.Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexesMolecular pathology of sarcomas: concepts and clinical implicationsOncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.Diverse roles and interactions of the SWI/SNF chromatin remodeling complex revealed using global approaches.Chromatin-regulating proteins as targets for cancer therapy.BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancerEpigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformationThe SWI/SNF subunit/tumor suppressor BAF47/INI1 is essential in cell cycle arrest upon skeletal muscle terminal differentiation.The limitations of simple gene set enrichment analysis assuming gene independence.An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.The role of genetics in the establishment and maintenance of the epigenome.SNF5 is an essential executor of epigenetic regulation during differentiation.Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis.Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumorsp16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.Promiscuous partnerships in Ewing's sarcoma.TCR-dependent transformation of mature memory phenotype T cells in mice.Rhabdoid Variant of Myoepithelial Carcinoma, with EWSR1 Rearrangement: Expanding the Spectrum of EWSR1-Rearranged Myoepithelial Tumors.SWItching on the transcriptional circuitry in melanoma.Chromatin structure following UV-induced DNA damage-repair or death?Metagene projection for cross-platform, cross-species characterization of global transcriptional statesChromatin Remodelers: From Function to Dysfunction.The chromatin remodeling and mRNA splicing functions of the Brahma (SWI/SNF) complex are mediated by the SNR1/SNF5 regulatory subunit.
P2860
Q24320038-4D763285-A69D-4304-A5B3-61D5990A76BAQ24633517-59EA14E0-BD2C-44EB-8A7C-BCF1D8753A46Q24671688-AF22BD94-D566-4493-9F6F-2FEFEC25E14FQ26768682-325674E9-3CE8-4C68-B4C5-9F5774D5CBEEQ26782730-BBD58CC6-F365-424B-AD52-6939CEECAADFQ26849467-B4BC995A-BF90-482E-99A4-5BACB7D90C62Q26998657-09324E8A-FA14-4B20-8139-4896966EDF0CQ27935182-EA160BFA-D293-496A-95FF-0AE31C7CB6C4Q30354457-27481A08-FB9C-4B79-B812-B0531B54EC9EQ30671578-D522DA16-3FA7-4774-B42F-BF769C409596Q33354938-5826F9C7-EF8A-4081-B501-D6EC9D24F34DQ33656437-8A47B443-4E20-4150-ACE1-6416A8D17F59Q33688157-6CAB2FAB-CDFB-457D-80AF-C4912CB30D3BQ33750535-3BD28868-9546-4245-83C8-147CECF3878EQ33751778-CC8BDC46-AE5C-488B-A488-6A468838D40FQ33844721-D3FA40A9-5FF0-4692-81DE-CD3796570122Q33847769-002B2C3B-1FF7-47F5-83A5-06D2E76BF5C3Q33907067-B7D0954F-A73F-4662-A4F0-FD505B1AA853Q34042035-2D900DB9-97ED-4758-99DA-C9838FF15469Q34213023-C5CA59E1-73BE-4837-B506-3CE3A965F282Q34278363-0F21371B-C991-41D7-B49C-94139A1FA4C2Q34306294-C6CFCB97-7C00-45C4-896E-9B51F278DC43Q34310916-C6AA009A-4FDA-4CAB-B817-87BF1853FC69Q34332647-EE0B4FCE-A74B-45C1-8B60-3373032F5377Q34455333-5A95587F-FE38-46D1-A91D-14009E0300AAQ34518342-09DB052D-CB7C-4F1C-9E41-E2ABAA97D990Q34649133-30878B29-6694-4976-B00B-302F6A17D95DQ34699803-3D567A41-BD8C-477E-92D4-FF4830B602ABQ34786042-0BC6B787-684D-41EE-BC5F-1B89C4E52304Q34997153-75EAB97F-8F43-4EFC-AB23-803EB1E1D2C1Q35035462-32DBA0D2-9D64-4895-93C5-81E00551F25BQ35133362-112BEDD1-174A-40BF-A02B-6DD9C43A874FQ35188770-7D99527A-C567-4933-8976-491EE646C62DQ35369863-E0374A65-AC9A-4418-B7C4-49CFF85FAC6CQ35582743-7B56B8F8-9BE0-49D4-9FC0-E902C43C9BFAQ35592205-0E338B1C-C43E-46CF-993B-348B3E792BAAQ35600207-DE7B2E3E-8AC8-4990-94A3-E4691A6F40E8Q35719918-CA86915E-5B79-4F42-B1B5-C50FCC0990C8Q35808490-9B04060F-A33B-400D-99C0-33B443762E4FQ36107018-4A5695C8-E99E-4F8A-AD8E-84899E7AD188
P2860
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@ast
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@en
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@nl
type
label
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@ast
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@en
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@nl
altLabel
Inactivation of the Snf5 tumor ...... ss in oncogenic transformation
@en
prefLabel
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@ast
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@en
Inactivation of the Snf5 tumor ...... s in oncogenic transformation.
@nl
P2093
P2860
P356
P1476
Inactivation of the Snf5 tumor ...... ss in oncogenic transformation
@en
P2093
Aravind Subramanian
Christine M Fillmore
Jaclyn A Biegel
Jill P Mesirov
Julia A Evans
Michael S Isakoff
Pablo Tamayo
Scott L Pomeroy
P2860
P304
17745-17750
P356
10.1073/PNAS.0509014102
P407
P577
2005-11-21T00:00:00Z